Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

31st Jul 2020 12:40

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing30 July 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,489,834

1.16%

465,202

0.36%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

355,000

0.28%

383,659

0.30%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,844,834

1.43%

848,861

0.66%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

21

209.4600 USD
Purchase

21

209.3300 USD
Purchase

33

209.5000 USD
Purchase

45

210.0753 USD
Purchase

214

210.0400 USD
Purchase

219

210.5494 USD
Purchase

231

211.2849 USD
Purchase

300

210.0266 USD
Purchase

372

209.1382 USD
Purchase

511

210.2649 USD
Purchase

527

210.0062 USD
Purchase

566

210.0213 USD
Purchase

739

210.1997 USD
Purchase

820

210.7530 USD
Purchase

1,102

210.9052 USD
Purchase

1,200

209.5846 USD
Purchase

1,283

210.5294 USD
Purchase

1,505

209.9055 USD
Purchase

1,528

209.2308 USD
Purchase

1,570

210.9748 USD
Purchase

2,334

209.4377 USD
Purchase

3,006

210.9555 USD
Purchase

4,560

209.5719 USD
Purchase

16,388

210.1398 USD
Purchase

30,511

211.4900 USD
Sale

3

210.0750 USD
Sale

3

210.0366 USD
Sale

4

209.9000 USD
Sale

4

210.0300 USD
Sale

4

209.9650 USD
Sale

4

210.4000 USD
Sale

6

210.0333 USD
Sale

8

210.2500 USD
Sale

8

210.1475 USD
Sale

8

210.0400 USD
Sale

8

210.4100 USD
Sale

16

209.9700 USD
Sale

33

209.5000 USD
Sale

42

209.3300 USD
Sale

100

210.0200 USD
Sale

100

209.7900 USD
Sale

100

211.7000 USD
Sale

100

211.4500 USD
Sale

200

211.1250 USD
Sale

400

209.7688 USD
Sale

716

209.2170 USD
Sale

885

211.3518 USD
Sale

898

209.7486 USD
Sale

1,394

209.2577 USD
Sale

1,428

209.2368 USD
Sale

2,100

209.3951 USD
Sale

3,538

209.6501 USD
Sale

9,756

210.6539 USD
Sale

15,691

210.0103 USD
Sale

31,377

211.4900 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

31 Jul 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200731005248/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,875.22
Change24.59